Tag: Immunoassay Market – Global Immunoassay Industry Size

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Enzyme Immunoassay Market Size, Value And Growth Trajectory Through 2030

The enzyme immunoassay market has experienced strong expansion in recent years. It is anticipated to increase from $21.5 billion in 2025 to $23.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. The historical growth in this sector can be attributed to factors such as the limited availability of automated EIA systems, the reliance on manual microplate readers, the development of clinical laboratory infrastructure, the rising prevalence of chronic and infectious diseases, and the adoption of conventional reagents and kits.

The enzyme immunoassay market is set for significant expansion over the next few years, with projections indicating a rise to $30.37 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period can be attributed to advancements like the development of fully automated EIA analyzers, the broadening scope of personalized medicine and precision diagnostics, increased integration of laboratory information systems, the growing embrace of software and data analysis tools, and heightened demand from academic and research institutions. Key trends anticipated in this period include the increasing adoption of automated EIA analyzers, an uptick in therapeutic drug monitoring applications, wider utilization of multiplex testing and high-throughput assays, the expansion of oncology and infectious disease testing, and an improved focus on laboratory data integration and workflow efficiency.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=81106220&type=smp&name=Enzyme%20Immunoassay%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Enzyme Immunoassay Market Expansion Drivers: What’s Shaping Future Growth?

The enzyme immunoassay market is projected to expand due to the escalating challenge posed by infectious diseases. These illnesses, caused by harmful microorganisms like bacteria, viruses, fungi, or parasites, are transmissible among individuals. The increasing severity of infectious diseases stems from antimicrobial resistance, which complicates the treatment of common infections, leading to prolonged sickness, elevated medical costs, and higher mortality rates. Enzyme immunoassays are essential for diagnosing infectious diseases as they enable the sensitive and specific detection of antigens or antibodies in patient samples, facilitating prompt identification, effective monitoring, and timely treatment of infections such as HIV, hepatitis, and influenza. For instance, in April 2025, the Minnesota Department of Health, a US-based government agency, reported that the proportion of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024, demonstrating a significant rise in this age group’s share of total cases. Consequently, the rising burden of infectious diseases is stimulating the growth of the enzyme immunoassay market.

Enzyme Immunoassay Market Segment Trends And Revenue Contributors

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

Enzyme Immunoassay Market Strategic Trends: What Defines The Next Growth Phase?

Leading companies in the enzyme immunoassay market are concentrating on bringing forth innovative enzyme immunoassay (EIA) solutions, such as fully automated enzyme immunoassays, to elevate diagnostic precision, diminish manual errors, and bolster workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays are defined as diagnostic systems that execute the entire testing process autonomously, consequently boosting speed, accuracy, and consistency in laboratory results. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, unveiled the fully automated Lumipulse G GFAP assay for research use only (RUO), thereby expanding its neuro-biomarker portfolio. This RUO chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) in human plasma and serum utilizing the LUMIPULSE G platform and yields results in just 35 minutes. It functions as an astrocytic biomarker associated with conditions like multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further enhances Fujirebio’s expanding neuro menu, which currently features NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.

Enzyme Immunoassay Market Leading Players And Competitive Positioning

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

View The Full Enzyme Immunoassay Market Report:

https://thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Enzyme Immunoassay Market Regional Distribution: Which Areas Power Market Growth?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Enzyme Immunoassay Market During 2026–2030?

The enzyme immunoassay market size has demonstrated robust growth in recent years. It is projected to increase from $21.5 billion in 2025 to $23.09 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historical expansion can be attributed to several factors including limited availability of automated eia systems, reliance on manual microplate readers, growing clinical laboratory infrastructure, increasing prevalence of chronic and infectious diseases, and the adoption of conventional reagents and kits.

The enzyme immunoassay market is projected to experience substantial expansion over the coming years. By 2030, this market is anticipated to reach a valuation of $30.37 billion, achieving a compound annual growth rate (CAGR) of 7.1%. This projected growth during the forecast period can be primarily attributed to several factors, including the advancement of fully automated EIA analyzers, the broadening scope of personalized medicine and precision diagnostics, the greater integration of laboratory information systems, an increase in the adoption of software and data analysis tools, and the increasing demand originating from academic and research institutions. Key trends expected within this period encompass the growing embrace of automated EIA analyzers, a surge in therapeutic drug monitoring applications, the expanding utilization of multiplex testing and high-throughput assays, the widened application in oncology and infectious disease testing, and an intensified emphasis on laboratory data integration and workflow efficiency.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

What Are The Main Drivers Accelerating The Growth Of The Enzyme Immunoassay Market?

The expanding prevalence of infectious diseases is anticipated to drive the advancement of the enzyme immunoassay market in the future. These diseases are ailments resulting from detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can transmit between individuals. The weight of infectious diseases is increasing because antimicrobial resistance complicates the treatment of everyday infections, leading to longer illnesses, elevated healthcare expenses, and a rise in fatalities. Enzyme immunoassays prove extremely beneficial in diagnosing infectious conditions, facilitating the precise and sensitive identification of antigens or antibodies within patient specimens. This capability supports prompt detection, efficient tracking, and opportune therapy for infections including HIV, hepatitis, and influenza. As an illustration, the Minnesota Department of Health, a US government body, reported in April 2025 that the proportion of HIV diagnoses among males between 35 to 39 years old climbed from 10% in 2023 to 17% in 2024, showing a significant rise in the percentage of total cases within this demographic. Consequently, the increasing incidence of infectious diseases is fueling the expansion of the enzyme immunoassay market.

How Does Segment Analysis Break Down The Enzyme Immunoassay Market Structure?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Trends Are Shaping The Enzyme Immunoassay Market Structure?

Key players in the enzyme immunoassay market are prioritizing the launch of inventive enzyme immunoassay (EIA) solutions, including fully automated enzyme immunoassays, to elevate diagnostic precision, diminish manual errors, and enhance the efficiency of laboratory workflows in clinical settings. Fully automated enzyme immunoassays refer to diagnostic systems that execute the complete testing procedure automatically, thereby boosting the speed, accuracy, and reliability of laboratory results. For example, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, introduced the fully automated Lumipulse G GFAP assay for research use only (RUO), thereby expanding its portfolio of neuro-biomarkers. This RUO chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) in human plasma and serum using the LUMIPULSE G platform, delivering results in a mere 35 minutes. It serves as an astrocytic biomarker associated with conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further enhances Fujirebio’s expanding neuro menu, which already encompasses NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.

Which Industry Players Are Present In The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Access The Complete Enzyme Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Commands The Largest Share Of The Enzyme Immunoassay Market?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Enzyme Immunoassay Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2026, By The Business Research Company

Enteral Feeding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-devices-global-market-report

Enteral Feeding Formula Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-formula-global-market-report

Enteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Are The Market Size Estimates For The Enzyme Immunoassay Market In 2026 And 2030?

The enzyme immunoassay market size has experienced robust growth in recent years. It is projected to increase from $21.5 billion in 2025 to $23.09 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.4%. The expansion observed in the historic period was largely due to the limited availability of automated eia systems, a reliance on manual microplate readers, the growing clinical laboratory infrastructure, the increasing prevalence of chronic and infectious diseases, and the adoption of conventional reagents and kits.

The enzyme immunoassay market is anticipated to undergo significant expansion in the coming years, with its size projected to reach $30.37 billion by 2030, growing at a compound annual growth rate (CAGR) of 7.1%. This expected growth throughout the forecast period stems from the advancement of fully automated EIA analyzers, the expansion of personalized medicine and precision diagnostics, the increasing integration of laboratory information systems, the rising adoption of software and data analysis tools, and a growing demand from academic and research institutions. Prominent trends identified for this period include the increased uptake of automated EIA analyzers, a surge in therapeutic drug monitoring applications, the broader utilization of multiplex testing and high-throughput assays, an expansion in oncology and infectious disease testing, and a heightened emphasis on laboratory data integration and workflow efficiency.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

Which Key Drivers Are Affecting The Enzyme Immunoassay Market Development?

The increasing prevalence of infectious diseases is expected to propel the expansion of the enzyme immunoassay market going forward. Infectious diseases are defined as illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread from person to person. The challenge of infectious diseases is escalating as antimicrobial resistance makes it progressively difficult to treat common infections, leading to prolonged illness, higher medical costs, and increased mortality. Enzyme immunoassays are highly valuable in the diagnosis of infectious diseases, as they allow for the sensitive and specific detection of antigens or antibodies in patient samples, enabling early identification, effective monitoring, and timely treatment of infections such as HIV, hepatitis, and influenza. For instance, in April 2025, according to the Minnesota Department of Health, a US-based government agency, the share of HIV cases among males aged 35 to 39 rose from 10% in 2023 to 17% in 2024, indicating a notable increase in this age group’s proportion of total cases. Consequently, the expanding burden of infectious diseases is driving the growth of the enzyme immunoassay market.

What Are The Main Segments Within The Enzyme Immunoassay Market Segment Structure?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Trends Are Transforming The Enzyme Immunoassay Market?

Leading companies in the enzyme immunoassay market are concentrating on introducing innovative enzyme immunoassay (EIA) solutions, such as fully automated enzyme immunoassays, aiming to enhance diagnostic accuracy, minimize manual errors, and improve workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays are defined as diagnostic systems that execute the entire testing process autonomously, thereby boosting speed, precision, and consistency in laboratory outcomes. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, launched the fully automated Lumipulse G GFAP assay exclusively for research use only (RUO), thereby expanding its neuro-biomarker portfolio. This particular RUO chemiluminescent enzyme immunoassay is designed to measure glial fibrillary acidic protein (GFAP) in human plasma and serum using the LUMIPULSE G platform, delivering results in a mere 35 minutes. It serves as an astrocytic biomarker linked to conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further strengthens Fujirebio’s expanding neuro menu, which currently features NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.

Who Are The Companies Participating In The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Get The Full Enzyme Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Leads The Enzyme Immunoassay Market In Terms Of Market Share?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Enzyme Immunoassay Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2026, By The Business Research Company

Enteral Feeding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-devices-global-market-report

Enteral Feeding Formula Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-formula-global-market-report

Enteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Enzyme Immunoassay Market In 2026 And What Value Is Projected For 2030?

The enzyme immunoassay market size has experienced significant expansion in recent years. This market is projected to expand from $21.5 billion in 2025 to $23.09 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion was driven by factors such as the restricted access to automated EIA systems, the dependence on manual microplate readers, the developing clinical laboratory infrastructure, a rising incidence of chronic and infectious conditions, and the use of traditional reagents and kits.

The enzyme immunoassay market is anticipated to experience substantial expansion over the upcoming years. It is projected to reach $30.37 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. This expansion during the projected period can be ascribed to advancements in fully automated EIA analyzers, the spread of personalized medicine and precise diagnostics, greater integration of laboratory information systems, an increase in the uptake of software and data analysis tools, and increasing demand from scholarly and scientific establishments. Key patterns expected during this forecast timeframe encompass the increasing implementation of automated EIA analyzers, a rise in therapeutic drug monitoring applications, enhanced utilization of multiplex testing and high-throughput assays, the broadening of oncology and infectious disease testing, and an amplified emphasis on laboratory data integration and operational efficiency.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

What Drivers Are Influencing The Enzyme Immunoassay Market?

The increasing prevalence of infectious diseases is anticipated to drive expansion in the enzyme immunoassay market. These diseases are conditions caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, capable of human-to-human transmission. The challenge of infectious diseases is escalating due to antimicrobial resistance, complicating the treatment of common infections and resulting in longer illnesses, higher healthcare expenses, and increased fatalities. Enzyme immunoassays offer significant diagnostic value for infectious diseases, facilitating precise and sensitive detection of antigens or antibodies in patient samples, which supports early detection, efficient tracking, and prompt management of conditions such as HIV, hepatitis, and influenza. An illustration of this is the data from April 2025 by the Minnesota Department of Health, a US-based government entity, showing that HIV cases among males aged 35 to 39 climbed from 10% in 2023 to 17% in 2024, highlighting a significant rise in this demographic’s share of total cases. Consequently, the expanding challenge posed by infectious diseases is propelling the growth of the enzyme immunoassay market.

What Are The Key Segments Of The Enzyme Immunoassay Market?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Key Trends Are Influencing The Development Of The Enzyme Immunoassay Market?

Leading companies operating within the enzyme immunoassay market are prioritizing the introduction of innovative enzyme immunoassay (EIA) solutions, such as fully automated enzyme immunoassays, to enhance diagnostic precision, minimize manual errors, and improve workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays are defined as diagnostic systems that autonomously carry out the entire testing process, thereby boosting the speed, accuracy, and consistency of laboratory results. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, unveiled the fully automated Lumipulse G GFAP assay for research use only (RUO), thereby expanding its portfolio of neuro-biomarkers. This RUO chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) in human plasma and serum utilizing the LUMIPULSE G platform, delivering results in just 35 minutes. It functions as an astrocytic biomarker implicated in conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further strengthens Fujirebio’s growing neuro menu, which already includes NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.

Who Are The Leading Companies Operating In The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Read the full enzyme immunoassay market report here:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Enzyme Immunoassay Market?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Enzyme Immunoassay Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2026, By The Business Research Company

Enteral Feeding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-devices-global-market-report

Enteral Feeding Formula Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-formula-global-market-report

Enteral Nutrition Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Enzyme Immunoassay Market between 2026 and 2030?

The enzyme immunoassay market size has experienced significant expansion in recent years. Forecasts indicate it will expand from $21.5 billion in 2025 to $23.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Historically, this growth can be ascribed to several factors, including the limited availability of automated eia systems, reliance on manual microplate readers, the expansion of clinical laboratory infrastructure, the rising prevalence of chronic and infectious diseases, and the adoption of conventional reagents and kits.

The enzyme immunoassay market is projected to experience substantial expansion over the coming years, anticipated to reach $30.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the forecast period include the advancement of fully automated EIA analyzers, the broadened scope of personalized medicine and precision diagnostics, the greater integration of laboratory information systems, the increasing uptake of software and data analysis tools, and the escalating demand from academic and research institutions. Key trends observed within the forecast period encompass the growing acceptance of automated EIA analyzers, an increase in therapeutic drug monitoring applications, the heightened utilization of multiplex testing and high-throughput assays, the broadening of oncology and infectious disease testing, and an intensified emphasis on laboratory data integration and workflow efficiency.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

Which Drivers Are Expected To Impact The Enzyme Immunoassay Market During The Forecast Period?

The increasing prevalence of infectious diseases is anticipated to boost the expansion of the enzyme immunoassay market. Infectious diseases are conditions caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals. This burden is intensifying due to growing antimicrobial resistance, complicating the treatment of common infections and resulting in extended illnesses, elevated healthcare expenditures, and higher death rates. Enzyme immunoassays are crucial for diagnosing these diseases, offering sensitive and specific identification of antigens or antibodies in patient samples, which facilitates prompt detection, efficient tracking, and timely intervention for infections such as HIV, hepatitis, and influenza. As an illustration, the Minnesota Department of Health, a US-based government entity, reported in April 2025 that the proportion of HIV cases among males aged 35 to 39 climbed from 10% in 2023 to 17% in 2024, showing a significant rise in this demographic’s share of overall cases. Consequently, the rising burden of infectious diseases is propelling the growth of the enzyme immunoassay market.

Which Segments Are Driving Activity In The Enzyme Immunoassay Market?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

Which Market Trends Are Opening Growth Opportunities In The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are focusing on introducing innovative enzyme immunoassay (EIA) solutions, including fully automated enzyme immunoassays, with the goal of improving diagnostic accuracy, reducing manual errors, and enhancing workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays represent diagnostic systems that perform the entire testing process automatically, thereby improving speed, accuracy, and consistency in laboratory results. For example, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, released the fully automated Lumipulse G GFAP assay for research use only (RUO), which expanded its neuro-biomarker portfolio. This particular RUO chemiluminescent enzyme immunoassay quantifies glial fibrillary acidic protein (GFAP) in human plasma and serum using the LUMIPULSE G platform, providing results in just 35 minutes. It functions as an astrocytic biomarker implicated in conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further enhances Fujirebio’s expanding neuro menu, which already includes NfL, pTau217, and sTREM2, supporting comprehensive neurodegenerative disease profiling on a single automated system.

Which Key Market Players Are Investing In Expansion And Innovation Within The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Enzyme Immunoassay Market?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Enzyme Immunoassay Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2026, By The Business Research Company

Enteral Feeding Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-devices-global-market-report

Enteral Feeding Formula Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-formula-global-market-report

Enteral Nutrition Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Enzyme Immunoassay Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The enzyme immunoassay market has demonstrated significant growth in recent years. It is anticipated to expand from $20.01 billion in 2024 to $21.50 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.4%. The historical development can be attributed to the escalating prevalence of infectious diseases, the expansion of blood screening initiatives, advancements in laboratory infrastructure, increased utilization in food safety testing, and the rising demand for veterinary diagnostics.

The enzyme immunoassay market is anticipated to experience substantial growth in the coming years, projected to reach $28.37 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.2%. This expansion during the forecast period is primarily attributed to government and NGO-led disease control initiatives, the increasing prevalence of autoimmune disease detection, the broader adoption of point-of-care testing, a rising demand for companion diagnostics in oncology, and an expanding geriatric population. Significant trends for the forecast period include technological advancements in microplate readers and reagents, the development of innovative diagnostic technologies, the creation of eco-friendly reagents, the integration of AI and automation into immunoassays, and strategic collaborations and partnerships.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

Which Drivers Are Shaping The Enzyme Immunoassay Industry’s Market Share?

The escalating prevalence of infectious illnesses is projected to fuel the expansion of the enzyme immunoassay market in the future. Infectious diseases are defined as ailments resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, capable of interpersonal transmission. The weight of infectious diseases is intensifying because antimicrobial resistance complicates the treatment of prevalent infections, leading to extended sickness, elevated healthcare expenditures, and a higher death rate. Enzyme immunoassays prove extremely valuable for diagnosing infectious diseases, given their capacity for sensitive and specific identification of antigens or antibodies within patient specimens, thereby facilitating prompt discovery, efficient oversight, and swift therapy for conditions like HIV, hepatitis, and influenza. For example, in April 2025, data from the Minnesota Department of Health, a US-based government agency, showed that the percentage of HIV cases among males aged 35 to 39 climbed from 10% in 2023 to 17% in 2024, signaling a significant rise in this demographic’s share of overall cases. Consequently, the escalating impact of infectious diseases is fostering the expansion of the enzyme immunoassay market.

What Are The Major Segment Types Covered In The Enzyme Immunoassay Market?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

What Long-Term Trends Will Shape The Future Growth Of The Enzyme Immunoassay Industry?

Leading companies active in the enzyme immunoassay market are prioritizing the introduction of innovative enzyme immunoassay (EIA) solutions, such as fully automated enzyme immunoassays, to elevate diagnostic precision, minimize manual errors, and enhance workflow efficiency in clinical laboratory environments. Fully automated enzyme immunoassays denote diagnostic systems that autonomously carry out the entire testing procedure, thereby improving speed, accuracy, and consistency in laboratory outcomes. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, unveiled the fully automated Lumipulse G GFAP assay for research use only (RUO), thus expanding its neuro-biomarker portfolio. This RUO chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) in human plasma and serum using the LUMIPULSE G platform and delivers results in just 35 minutes. It functions as an astrocytic biomarker implicated in conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further strengthens Fujirebio’s expanding neuro menu, which already encompasses NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a singular automated system.

Which Major Industry Participants Are Leading The Enzyme Immunoassay Market Growth?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Enzyme Immunoassay Market?

North America was the largest region in the enzyme immunoassay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Enzyme Immunoassay Market Report:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2025, By The Business Research Company

Immunoassay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Enzyme Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/enzyme-global-market-report

In Vitro Diagnostics Enzymes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model